Professor, Internal Medicine, University of Texas Southwestern Medical Center, Southwestern Medical School
Gastroenterology
Dr. Byron L. Cryer, MD
|
|
Give Review
Byron Cryer is an expert in the field of Gastroenterology. He studied medicine at Baylor College of Medicine. He received awards:"Fellow (FACG)". Doctor Byron L. Cryer, MD is also a published physician. He has 80 publication published. The most recent publication is: The advent of highly selective inhibitors of cyclooxygenase--a review.
Publications
- Helicobacter pylori Clarithromycin Resistance and Treatment Failure Are Common in the USA.
- Walter (Pete) L. Peterson, MD, 1943-2015.
- A Randomized Study of Lubiprostone for Opioid-Induced Constipation in Patients with Chronic Noncancer Pain.
- Helicobacter gastritis induces changes in the oxyntic mucosa indistinguishable from the effects of proton pump inhibitors.
- Evaluation and Management of the Atrial Fibrillation Patient: A Report From the Society of Cardiovascular Patient Care.
- Low Rate of Post-Polypectomy Bleeding Among Patients Who Continue Thienopyridine Therapy During Colonoscopy.
- GI-REASONS: A Novel 6-Month, Prospective, Randomized, Open-Label, Blinded Endpoint (PROBE) Trial.
- Proton Pump Inhibitors Increase the Incidence of Bone Fractures in Hepatitis C Patients.
- The Cross-Sectional Relationship of Hemoglobin Levels and Functional Outcomes in Women with Self-Reported Osteoarthritis: Results from the Women's Health Initiative.
- Do non-steroidal anti-inflammatory drugs cause exacerbations of inflammatory bowel Disease?
- Acetaminophen not associated with gastroIntestinal toxicity: comment on the article by Rahme et al.
- GastroIntestinal injury associated with NSAID use: a case study and review of risk factors and preventative strategies.
- Oral bisphosphonates and upper gastroIntestinal tract problems: what is the evidence?
- Reducing the gastroIntestinal risks of low-dose aspirin.
- A COX-2-specific inhibitor plus a proton-pump inhibitor: is this a reasonable approach to reduction in NSAIDs' GI toxicity?
- The importance of addressing the condition of nonsteroidal anti-inflammatory drug-related gastropathy.
- Peptic ulcer Disease in the elderly.
- Factors influencing gastroduodenal mucosal prostaglandin concentrations: roles of smoking and aging.
- Three-year oral pantoprazole administration is effective for patients with Zollinger-Ellison syndrome and other hypersecretory conditions.
- Diarrhea associated with mesalamine in a patient with chronic nongranulomatous enteroColitis.
- NSAID-associated deaths: the rise and fall of NSAID-associated GI mortality.
- COX-2-specific inhibitor or proton pump inhibitor plus traditional NSAID: is either approach sufficient for patients at highest risk of NSAID-induced ulcers?
- Dose effects of aspirin on gastric prostaglandins and stomach mucosal injury.
- Role of seroconversion in confirming cure of Helicobacter pylori infection.
- Effects of age on gastric alkaline and nonparietal fluid secretion in humans.
- Gastric mucosal biopsy via a nasogastric tube: a nonendoscopic method for diagnosing fundic and antral mucosal gastritis and Helicobacter pylori infection in man.
- Effects of aging and gastritis on gastric acid and pepsin secretion in humans: a prospective study.
- Meeting the gastroIntestinal needs of a culturally and linguistically diverse patient population.
- Effects of Helicobacter pylori gastritis on gastric secretion in healthy human beings.
- Nonsteroidal anti-inflammatory drug gastroIntestinal toxicity.
- Mucosal defense and repair. Role of prostaglandins in the stomach and duodenum.
- Tegaserod-induced myocardial infarction: case report and hypothesis.
- NSAID gastroIntestinal toxicity.
- Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humans.
- Time course inhibition of gastric and platelet COX activity by acetylsalicylic acid in humans.
- Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human Esophageal adenocarcinoma cells.
- The advent of highly selective inhibitors of cyclooxygenase--a review.
- Effects of cutaneous aspirin on the human stomach and duodenum.
- Racial differences in gastric function among African Americans and Caucasian Americans: secretion, serum gastrin, and histology.
- Influence of H. pylori infection on meal-stimulated gastric acid secretion and gastroEsophageal acid reflux.
- A randomized, controlled comparison of ibuprofen at the maximal over-the-counter dose compared with prescription-dose celecoxib on upper gastroIntestinal mucosal injury.
- Epidemiology and role of nonsteroidal antiinflammatory drugs in causing gastroIntestinal bleeding.
- Effects of nonsteroidal anti-inflammatory drugs on endogenous gastroIntestinal prostaglandins and therapeutic strategies for prevention and treatment of nonsteroidal a...
- Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs.
- Evidence for endoscopic ulcers as meaningful surrogate endpoint for clinically significant upper gastroIntestinal harm.
- Duration of the interval between the completion of bowel preparation and the start of colonoscopy predicts bowel-preparation quality.
- Effects of low-dose aspirin on serum C-reactive protein and thromboxane B2 concentrations: a placebo-controlled study using a highly sensitive C-reactive protein assay.
- Celecoxib plus aspirin versus naproxen and lansoprazole plus aspirin: a randomized, double-blind, endoscopic trial.
- Role of Helicobacter pylori infection in gastroduodenal injury and gastric prostaglandin synthesis during long term/low dose aspirin therapy: a prospective placebo-con...
- Aspirin absorption rates and platelet inhibition times with 325-mg buffered aspirin tablets (chewed or swallowed intact) and with buffered aspirin solution.
- A comparison of every-third-day versus daily low-dose aspirin therapy on serum thromboxane concentrations in healthy men and women.
- GastroIntestinal safety of low-dose aspirin.
- COX-2-specific inhibitors: prescribing patterns in a large managed care health system and strategies to minimize costs.
- The association of elevated HbA1c on the behavior of adenomatous polyps in patients with type-II diabetes mellitus.
- Management of patients with high gastroIntestinal risk on antiplatelet therapy.
- GastroIntestinal side effects of nonsteroidal anti-inflammatory drugs.
- The risk of acute myocardial infarction with etodolac is not increased compared to naproxen: a historical cohort analysis of a generic COX-2 selective inhibitor.
- Patterns of use and public perception of over-the-counter pain relievers: focus on nonsteroidal antiinflammatory drugs.
- Consensus development conference on the use of nonsteroidal anti-inflammatory agents, including cyclooxygenase-2 enzyme inhibitors and aspirin.
- Upper gastroIntestinal tolerability of once weekly alendronate 70 mg with concomitant non-steroidal anti-inflammatory drug use.
- Double-blind, randomized, parallel, placebo-controlled study of ibuprofen effects on thromboxane B2 concentrations in aspirin-treated healthy adult volunteers.
- A novel composite endpoint to evaluate the gastroIntestinal (GI) effects of nonsteroidal antiinflammatory drugs through the entire GI tract.
- Risks of clinically significant upper gastroIntestinal events with etodolac and naproxen: a historical cohort analysis.
- A randomized, placebo-controlled, 6-month study of once-weekly alendronate oral solution for postmenopausal osteoporosis.
- Reducing the risks of gastroIntestinal bleeding with antiplatelet therapies.
- Lower gastroIntestinal events in a double-blind trial of the cyclo-oxygenase-2 selective inhibitor etoricoxib and the traditional nonsteroidal anti-inflammatory drug d...
- Elevated HbA1c is an independent predictor of aggressive clinical behavior in patients with colorectal cancer: a case-control study.
- Risk factors for NSAID-associated upper GI clinical events in a long-term prospective study of 34 701 arthritis patients.
- Assessment of upper gastroIntestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and D...
- Low-dose aspirin-induced ulceration is attenuated by aspirin-phosphatidylcholine: a randomized clinical trial.
- Persistence with non-selective NSAIDs and celecoxib among patients with gastroesophageal reflux Disease and osteoarthritis or rheumatoid arthritis.
- Effect of concomitant use of clopidogrel and proton pump inhibitors after percutaneous coronary intervention.
- Barriers to nuclease Bal31 digestion across specific sites in simian virus 40 chromatin.
- The economics of upper gastroIntestinal bleeding in a US managed-care setting: a retrospective, claims-based analysis.
- Drug-induced injury in the gastroIntestinal tract: clinical and pathologic considerations.
- Mortality associated with gastroIntestinal bleeding events: Comparing short-term clinical outcomes of patients hospitalized for upper GI bleeding and acute myocardial ...
- Clopidogrel with or without omeprazole in coronary artery Disease.
- A fixed-dose combination of naproxen and esomeprazole magnesium has comparable upper gastroIntestinal tolerability to celecoxib in patients with osteoarthritis of the ...
- Proton-Pump Inhibitors Reduce GastroIntestinal Events Regardless of Aspirin Dose in Patients Requiring Dual Antiplatelet Therapy.
Schools
Baylor University
Baylor College Of Med
Dallas Co Hp Parkland Mem
Procedures Preformed
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
Conditions Treated
- Anemia
- Crohn's Disease (Regional Enteritis)
- Diaphragmatic and-or Hiatal Hernia
- Diverticulosis, Intestinal
- View All
Doctors Specialties
- Gastroenterology
Accepted Insurances
Awards
- Fellow (FACG)
Education
-
Baylor College of Medicine
Hospital
-
University of Texas Southwestern Medical Center -
Veterans Affairs North Texas Health Care System
Helpful Reviews
Similar Doctors
|
|
Dr. Jeffrey D. Linder, MD |
|
|
Dr. Leonard A. Berry Jr., MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sami N. Arslanlar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John W. Secor, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kimberley Persley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hadi M. Siddiqui, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Deepak Agrawal, MB
This Doctor is OpenDoctor Recommended.
|